Harmony Biosciences Inc.

NASDAQ: HRMY · Real-Time Price · USD
36.88
0.37 (1.01%)
At close: Aug 15, 2025, 3:59 PM
36.87
-0.03%
After-hours: Aug 15, 2025, 04:10 PM EDT

Harmony Biosciences Statistics

Share Statistics

Harmony Biosciences has 57.53M shares outstanding. The number of shares has increased by 1.04% in one year.

57.53M
1.04%
0.14%
87.45%
43.69M
6,687
1.05%

Short Selling Information

The latest short interest is 4.45M, so 7.74% of the outstanding shares have been sold short.

4.45M
7.74%
16.99%
8.21

Valuation Ratios

The PE ratio is 13.45 and the forward PE ratio is 8.78. Harmony Biosciences's PEG ratio is 0.75.

13.45
8.78
2.74
2
2.97
8.95
0.75
Financial Ratio History

Enterprise Valuation

Harmony Biosciences has an Enterprise Value (EV) of 1.68B.

2.36
7.21
7.66
7.7

Financial Position

The company has a current ratio of 3.31, with a Debt / Equity ratio of 0.27.

3.31
3.27
0.27
0.77
0.82
10.91

Financial Efficiency

Return on Equity is 22.07% and Return on Invested Capital is 17.22%.

22.07%
14.56%
17.22%
$2.67M
$542.88K
268
0.72
21.79

Taxes

46.31M
24.14%

Stock Price Statistics

The stock price has increased by 4.25% in the last 52 weeks. The beta is 0.84, so Harmony Biosciences's price volatility has been higher than the market average.

0.84
4.25%
34.24
34.13
45.79
637,469

Income Statement

In the last 12 months, Harmony Biosciences had revenue of 714.73M and earned 145.49M in profits. Earnings per share was 2.56.

714.73M
557.92M
190.83M
145.49M
233.41M
209.3M
2.56
Full Income Statement

Balance Sheet

The company has 453M in cash and 179.27M in debt, giving a net cash position of 273.74M.

453M
179.27M
273.74M
2.22M
1.11B
511.22M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 219.82M and capital expenditures -1.15M, giving a free cash flow of 218.67M.

219.82M
-1.15M
218.67M
3.84
Full Cash Flow Statement

Margins

Gross margin is 78.06%, with operating and profit margins of 26.7% and 20.36%.

78.06%
26.7%
26.84%
20.36%
32.66%
26.7%
30.59%

Dividends & Yields

HRMY does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
7.43%
11.17%
Dividend Details

Analyst Forecast

The average price target for HRMY is $52.5, which is 50.7% higher than the current price. The consensus rating is "Buy".

$52.5
50.7%
Buy
15
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
25.82
-25.87%

Scores

5.59
7